These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17334372)

  • 1. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.
    Yang Z; Chang YJ; Yu IC; Yeh S; Wu CC; Miyamoto H; Merry DE; Sobue G; Chen LM; Chang SS; Chang C
    Nat Med; 2007 Mar; 13(3):348-53. PubMed ID: 17334372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
    Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
    Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse.
    Tokui K; Adachi H; Waza M; Katsuno M; Minamiyama M; Doi H; Tanaka K; Hamazaki J; Murata S; Tanaka F; Sobue G
    Hum Mol Genet; 2009 Mar; 18(5):898-910. PubMed ID: 19066230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.
    Katsuno M; Adachi H; Tanaka F; Sobue G
    J Mol Med (Berl); 2004 May; 82(5):298-307. PubMed ID: 15133611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
    Adachi H; Waza M; Tokui K; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
    J Neurosci; 2007 May; 27(19):5115-26. PubMed ID: 17494697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein.
    Adachi H; Katsuno M; Minamiyama M; Sang C; Pagoulatos G; Angelidis C; Kusakabe M; Yoshiki A; Kobayashi Y; Doyu M; Sobue G
    J Neurosci; 2003 Mar; 23(6):2203-11. PubMed ID: 12657679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).
    Katsuno M; Adachi H; Inukai A; Sobue G
    Cytogenet Genome Res; 2003; 100(1-4):243-51. PubMed ID: 14526186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
    Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.
    Montie HL; Cho MS; Holder L; Liu Y; Tsvetkov AS; Finkbeiner S; Merry DE
    Hum Mol Genet; 2009 Jun; 18(11):1937-50. PubMed ID: 19279159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
    Matsuura T
    Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.
    Waza M; Adachi H; Katsuno M; Minamiyama M; Sang C; Tanaka F; Inukai A; Doyu M; Sobue G
    Nat Med; 2005 Oct; 11(10):1088-95. PubMed ID: 16155577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
    Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
    Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease.
    Qiang Q; Adachi H; Huang Z; Jiang YM; Katsuno M; Minamiyama M; Doi H; Matsumoto S; Kondo N; Miyazaki Y; Iida M; Tohnai G; Sobue G
    J Neurochem; 2013 Jul; 126(1):122-30. PubMed ID: 23363377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro aggregation and cellular toxicity of mutant androgen receptor protein in spinal and bulbar muscular atrophy].
    Kobayashi Y; Li M; Sobue G
    Nihon Rinsho; 1999 Apr; 57(4):874-9. PubMed ID: 10222782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.
    Katsuno M; Adachi H; Doyu M; Minamiyama M; Sang C; Kobayashi Y; Inukai A; Sobue G
    Nat Med; 2003 Jun; 9(6):768-73. PubMed ID: 12754502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the effects and molecular mechanisms of dimethylcurcumin (ASC-J9) on androgen receptor-related diseases.
    Hu H; Zhou H; Xu D
    Chem Biol Drug Des; 2021 Apr; 97(4):821-835. PubMed ID: 33277796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor (AR) degradation enhancer ASC-J9
    Cheng MA; Chou FJ; Wang K; Yang R; Ding J; Zhang Q; Li G; Yeh S; Xu D; Chang C
    Cancer Lett; 2018 Mar; 417():182-191. PubMed ID: 29203251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
    Banno H; Katsuno M; Suzuki K; Takeuchi Y; Kawashima M; Suga N; Takamori M; Ito M; Nakamura T; Matsuo K; Yamada S; Oki Y; Adachi H; Minamiyama M; Waza M; Atsuta N; Watanabe H; Fujimoto Y; Nakashima T; Tanaka F; Doyu M; Sobue G
    Ann Neurol; 2009 Feb; 65(2):140-50. PubMed ID: 19259967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
    Baniahmad A
    J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.
    Lai KP; Huang CK; Chang YJ; Chung CY; Yamashita S; Li L; Lee SO; Yeh S; Chang C
    Am J Pathol; 2013 Feb; 182(2):460-73. PubMed ID: 23219429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.